I-lab2018 Bpifrance

Jul 23, 2018

Exeliom Biosciences is awarded I-Lab2018 from Bpifrance

Deeptech Bpifrance Microbiome

Aug 12, 2019

Exeliom Biosciences is awarded 1.8M€ DeepTech grant from Bpifrance to advance its lead program

Clinical Trial Live Biotherapeutics Crohn's Disease Belgium

Feb 24, 2022

Exeliom Biosciences announces approval of Clinical Trial Application from the Belgian Agency for Single Strain Live Biotherapeutic EXL01 (Faecalibacterium prausnitzii) for the treatment of Crohn’s Disease

Apr 11, 2024

Exeliom Biosciences announces three phase II clinical trials in immuno-oncology with lead candidate combined with immune checkpoint inhibitors

contact

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.